55 results

• Diabetics May Face Increased Risk of Pancreatic Cancer: Study

  January 8, 2015

  Irvin Jackson

  A new study links blood glucose levels to an increased risk of pancreatic cancer.

• Judge Denies Plaintiff Request for Source Data on Byetta, Januvia Problems

  October 9, 2014

  Austin Kirk

  A federal judge has rejected a call for access to source data on adverse event reports tied to some diabetes drugs and pancreatic cancer, saying it would lead to the court overstepping its bounds.

• New Diabetic Drug Similar to Byetta, Victoza Approved, Despite Cancer Risks

  September 19, 2014

  Irvin Jackson

  The FDA has approved a new diabetes drug, Trulicity, that may carry similar thyroid and pancreatic cancer risks as existing diabetes treatments.

• Byetta Settlements Reached in 84 Cases, But Hundreds of Lawsuits Remain

  August 8, 2014

  Austin Kirk

  AstraZeneca announced it has settled 84 Byetta lawsuits, but still faces more than 400 claims involving allegations that the diabetes drug caused pancreatic cancer, thyroid cancer or pancreatitis.

• Discovery Moving Forward in Byetta, Januvia Cancer Lawsuits

  July 2, 2014

  Austin Kirk

  Following a status conference, deadlines for discovery have been established in the pancreatic cancer lawsuits.

• Bydureon Side Effects Linked to Injection Site Reactions

  June 17, 2014

  Irvin Jackson

  Bydureon, a long-acting version of Byetta, has been linked to severe injection site reactions, the FDA warns.

• Victoza Recall Urged By Public Citizen Over Pancreatitis Risks

  June 6, 2014

  Irvin Jackson

  Public Citizen is demanding the FDA ban Victoza from the market following a report the group says shows a causal link between the diabetes drug and acute pancreatitis.

• Januvia, Byetta Pancreatitis Risk Questioned by Researchers

  April 25, 2014

  Irvin Jackson

  Chinese researchers say they could find no link between incretin mimetic-based diabetes drugs and an increased risk of pancreatitis.

• Nesina Leads Similar Diabetes Drugs in Adverse Events: Report

  April 17, 2014

  Irvin Jackson

  A look at diabetes drug adverse event reports suggests Nesina is the most dangerous and finds evidence of pancreatic cancer risks.

• Diabetes Drug Pancreatic Cancer Risk Questioned by FDA, EMA

  February 27, 2014

  Irvin Jackson

  The FDA and EMA say they can find no link between certain diabetes drugs and pancreatic cancer, despite other studies to the contrary.